
Bruker Corporation BRKR
$ 45.69
1.24%
Quarterly report 2025-Q3
added 11-05-2025
Bruker Corporation Total Non Current Liabilities 2011-2025 | BRKR
Annual Total Non Current Liabilities Bruker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 1.28 B | 1.21 B | 624 M | 690 M | 591 M | 443 M | 510 M | 490 M | 465 M | 330 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.28 B | 330 M | 663 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Abiomed
ABMD
|
19.1 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.82 | -1.04 % | $ 132 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
1.35 B | $ 307.08 | -0.33 % | $ 8.66 B | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
25.7 B | $ 128.67 | 2.55 % | $ 224 B | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 91.95 | -0.67 % | $ 135 B | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.18 | 10.56 % | $ 119 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
Eargo
EAR
|
161 M | - | - | $ 10.2 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 9.58 | -2.84 % | $ 688 M | ||
|
InMode Ltd.
INMD
|
12 M | $ 14.35 | -1.1 % | $ 1.14 B | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 0.99 | 7.52 % | $ 16 M | ||
|
IRadimed Corporation
IRMD
|
4.76 M | $ 96.99 | 0.79 % | $ 1.23 B | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
184 M | $ 163.04 | -1.44 % | $ 12.2 B | ||
|
Accuray Incorporated
ARAY
|
196 M | $ 1.04 | -2.06 % | $ 107 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 12.5 | -1.66 % | $ 338 M | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 14.9 | 0.99 % | $ 97.7 M | ||
|
AxoGen
AXGN
|
1.61 M | $ 30.0 | -1.3 % | $ 1.33 B | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
877 M | $ 40.3 | -1.29 % | $ 1.24 B | ||
|
LivaNova PLC
LIVN
|
516 M | $ 63.28 | 0.84 % | $ 3.43 B | ||
|
OrthoPediatrics Corp.
KIDS
|
84.7 M | $ 17.83 | 1.31 % | $ 411 M | ||
|
Globus Medical
GMED
|
18.2 M | $ 86.73 | 0.05 % | $ 11.8 B | ||
|
LENSAR
LNSR
|
3.44 M | $ 11.51 | -0.04 % | $ 133 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 13.51 | 0.67 % | $ 1.04 B | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
Alphatec Holdings
ATEC
|
89.9 M | $ 19.79 | -0.85 % | $ 2.83 B | ||
|
Aethlon Medical
AEMD
|
42.5 K | $ 3.07 | -9.71 % | $ 4.79 M | ||
|
Establishment Labs Holdings
ESTA
|
53.7 M | $ 72.39 | -0.17 % | $ 2.04 B |